SOLVAY SA financials
SOLVAY SA
Country: BE Reporting currency: EUR Latest annual report: 2024-12-31
LEI:
549300MMVL80RTBP3O28 ISIN: BE0003470755 Financial statements
(EUR, as reported — unscaled; 122 line items across 2 annual periods)
| Line item | 2024 | 2023 |
|---|---|---|
| Income statement | ||
| Revenue | €5.13B | €6.02B |
| Cost of sales | €3.98B | €4.64B |
| Gross profit | €1.15B | €1.38B |
| Administrative expenses | €326.0M | €426.0M |
| Operating profit (EBIT) | €433.0M | €278.0M |
| Profit before tax | €320.0M | €180.0M |
| Income tax expense | €87.0M | €208.0M |
| Profit for the year | €233.0M | €2.10B |
| Total comprehensive income | €309.0M | €1.91B |
| Per share | ||
| Basic EPS | €2.12 | €20.09 |
| Diluted EPS | €2.10 | €19.85 |
| Free cash flow / share | €3.09 | €8.90 |
| Cash flow statement | ||
| Net cash from operating activities | €615.0M | €1.91B |
| Net cash from investing activities | -€281.0M | -€1.79B |
| Purchase of PP&E (capex) | €272.0M | €967.0M |
| Purchase of intangibles | €13.0M | €97.0M |
| Net cash from financing activities | -€364.0M | -€455.0M |
| Dividends paid | €260.0M | €424.0M |
| Proceeds from borrowings | €1.68B | €3.22B |
| Repayments of borrowings | €1.74B | €1.50B |
| Lease liability payments | €63.0M | €112.0M |
| Net change in cash | -€30.0M | -€335.0M |
| Balance sheet | ||
| Total assets | €6.69B | €7.02B |
| Non-current assets | €4.24B | €4.31B |
| Property, plant & equipment | €2.15B | €2.14B |
| Right-of-use assets | €264.0M | €267.0M |
| Intangible assets & goodwill | €782.0M | €764.0M |
| Current assets | €2.45B | €2.71B |
| Inventories | €623.0M | €642.0M |
| Trade & other receivables | €826.0M | €840.0M |
| Cash & equivalents | €539.0M | €584.0M |
| Total equity | €1.40B | €1.30B |
| Non-controlling interests | €65.0M | €42.0M |
| Non-current liabilities | €3.40B | €3.52B |
| Long-term borrowings | €1.98B | €1.98B |
| Current liabilities | €1.89B | €2.19B |
| Deferred tax liabilities | €136.0M | €131.0M |
| Derived metrics | ||
| Free cash flow | €343.0M | €944.0M |
| Operating margin | 8.4% | 4.6% |
| Net margin | 4.5% | 34.9% |
| Return on equity | 16.6% | 161.3% |
| Cash conversion ratio | 2.64× | 0.91× |
| Capex coverage | 2.26× | 1.98× |
| Other reported items | ||
| Adjustments For Depreciation and Amortisation Expense and Impairment Loss Reversal of Impairment Loss Recognised In Profit Or Loss | €362.0M | €994.0M |
| Adjustments For Finance Income Cost | -€111.0M | -€178.0M |
| Adjustments For Income Tax Expense | €87.0M | €450.0M |
| Adjustments For Provisions | €250.0M | €644.0M |
| Adjustments For Undistributed Profits of Investments Accounted For Using Equity Method | €38.0M | €71.0M |
| Basic Earnings Loss Per Share From Continuing Operations | €2.12 | €-0.36 |
| Basic Earnings Loss Per Share From Discontinued Operations | €0.00 | €20.45 |
| Cash Flows From Used In Financing Activities Discontinued Operations | €0 | -€64.0M |
| Cash Flows From Used In Investing Activities Discontinued Operations | €0 | -€675.0M |
| Cash Flows From Used In Operating Activities Discontinued Operations | €0 | €1.11B |
| Cash Flows Used In Obtaining Control of Subsidiaries Or Other Businesses Classified As Investing Activities | €0 | €2.0M |
| Comprehensive Income Attributable To Noncontrolling Interests | €11.0M | €11.0M |
| Comprehensive Income Attributable To Owners of Parent | €298.0M | €1.90B |
| Current Borrowings and Current Portion of Noncurrent Borrowings | €155.0M | €211.0M |
| Current Dividend Payables | €107.0M | €175.0M |
| Current Tax Assets Current | €51.0M | €66.0M |
| Current Tax Liabilities Current | €43.0M | €68.0M |
| Deferred Tax Assets | €301.0M | €317.0M |
| Diluted Earnings Loss Per Share From Continuing Operations | €2.10 | €-0.35 |
| Diluted Earnings Loss Per Share From Discontinued Operations | €0.00 | €20.20 |
| Dividends Proposed Or Declared Before Financial Statements Authorised For Issue But Not Recognised As Distribution To Owners | €154.0M | — |
| Dividends Proposed Or Declared Before Financial Statements Authorised For Issue But Not Recognised As Distribution To Owners Per Share | €2.43 | — |
| Dividends Received Classified As Investing Activities | €1.0M | €1.0M |
| Dividends Received Classified As Operating Activities | €21.0M | €25.0M |
| Effect of Exchange Rate Changes On Cash and Cash Equivalents | -€15.0M | -€13.0M |
| Equity and Liabilities | €6.69B | €7.02B |
| Equity Instruments Held | €63.0M | €88.0M |
| Expense Due To Unwinding of Discount On Provisions | €15.0M | €62.0M |
| Gains Losses On Cash Flow Hedges Before Tax | €48.0M | -€228.0M |
| Gains Losses On Exchange Differences On Translation Before Tax | €4.0M | -€138.0M |
| Gains Losses On Financial Assets At Fair Value Through Profit Or Loss | -€22.0M | €4.0M |
| Income From Continuing Operations Attributable To Owners of Parent | €223.0M | -€37.0M |
| Income From Discontinued Operations Attributable To Owners of Parent | €0 | €2.13B |
| Income Tax Relating To Components of Other Comprehensive Income | -€24.0M | €2.0M |
| Income Taxes Paid Refund Classified As Operating Activities | €109.0M | €434.0M |
| Increase Decrease In Cash and Cash Equivalents Discontinued Operations | €0 | €368.0M |
| Increase Decrease In Working Capital | -€1.0M | €78.0M |
| Increase Decrease Through Transfers and Other Changes Equity | €17.0M | €84.0M |
| Increase Decrease Through Treasury Share Transactions | -€31.0M | €39.0M |
| Intangible Assets Other Than Goodwill | €217.0M | €201.0M |
| Interest Expense | €108.0M | €71.0M |
| Interest Paid Classified As Financing Activities | €57.0M | €38.0M |
| Investment Accounted For Using Equity Method | €216.0M | €230.0M |
| Issued Capital | €237.0M | €237.0M |
| Liabilities | €5.29B | €5.72B |
| Noncurrent Investments Other Than Investments Accounted For Using Equity Method | €29.0M | €33.0M |
| Noncurrent Provisions For Employee Benefits | €674.0M | €793.0M |
| Other Adjustments For Noncash Items | -€48.0M | -€1.48B |
| Other Cash Payments To Acquire Equity Or Debt Instruments of Other Entities Classified As Investing Activities | €13.0M | €12.0M |
| Other Comprehensive Income | €76.0M | -€192.0M |
| Other Comprehensive Income Before Tax Gains Losses From Investments In Equity Instruments | €0 | €0 |
| Other Comprehensive Income Before Tax Gains Losses On Remeasurements of Defined Benefit Plans | €60.0M | -€30.0M |
| Other Comprehensive Income That Will Be Reclassified To Profit Or Loss Before Tax | €41.0M | -€164.0M |
| Other Comprehensive Income That Will Not Be Reclassified To Profit Or Loss Before Tax | €60.0M | -€30.0M |
| Other Current Financial Assets | €16.0M | €118.0M |
| Other Current Liabilities | €458.0M | €585.0M |
| Other Current Receivables | €396.0M | €462.0M |
| Other Finance Income Cost | €15.0M | -€6.0M |
| Other Gains Losses | -€91.0M | €15.0M |
| Other Inflows Outflows of Cash Classified As Financing Activities | €34.0M | -€337.0M |
| Other Longterm Provisions | €556.0M | €550.0M |
| Other Noncurrent Liabilities | €54.0M | €70.0M |
| Other Shortterm Provisions | €315.0M | €302.0M |
| Payments From Changes In Ownership Interests In Subsidiaries | €0 | €0 |
| Payments of Other Equity Instruments | €1.0M | €1.31B |
| Proceeds From Disposals of Property Plant and Equipment Intangible Assets Other Than Goodwill Investment Property and Other Noncurrent Assets | €11.0M | €7.0M |
| Proceeds From Issuing Other Equity Instruments | €0 | €0 |
| Profit Loss From Continuing Operations | €233.0M | -€28.0M |
| Profit Loss From Continuing Operations Attributable To Noncontrolling Interests | €10.0M | €9.0M |
| Profit Loss From Discontinued Operations | €0 | €2.13B |
| Profit Loss From Discontinued Operations Attributable To Noncontrolling Interests | €0 | €2.0M |
| Research and Development Expense | €34.0M | €47.0M |
| Revenue From Interest | €17.0M | €36.0M |
| Sales and Marketing Expense | €93.0M | €100.0M |
| Share of Other Comprehensive Income of Associates and Joint Ventures Accounted For Using Equity Method That Will Be Reclassified To Profit Or Loss Before Tax | -€11.0M | €202.0M |
| Share of Other Comprehensive Income of Associates and Joint Ventures Accounted For Using Equity Method That Will Not Be Reclassified To Profit Or Loss Before Tax | €0 | €0 |
| Share of Profit Loss of Associates and Joint Ventures Accounted For Using Equity Method | €38.0M | €53.0M |
| Share Premium | €174.0M | €174.0M |
| Trade and Other Current Payables To Trade Suppliers | €810.0M | €850.0M |
Methodology
Every line item above is a fact tagged in SOLVAY SA's annual report
filed in the European Single Electronic Format (ESEF) under the IFRS
taxonomy (ifrs-full) — the income statement, balance sheet
and cash-flow statement as the filer reported them. Values are shown
as-is, in the reporting currency (EUR), without
rescaling; the row labels map to the underlying concept name (e.g.
Revenue → ifrs-full:Revenue, Operating profit →
ifrs-full:ProfitLossFromOperatingActivities, Diluted EPS →
ifrs-full:DilutedEarningsLossPerShare), and any concept
without a curated label is shown under “Other reported items” with its
de-camel-cased tag name. Only consolidated, default-member facts are
shown (segment / dimensional breakdowns are excluded).
“Derived metrics” (free cash flow, margins, ROE, …) are computed from those facts by the same model the U.S. financials pages use — not tagged by the filer.
Source: machine-readable OIM xBRL-JSON aggregated by filings.xbrl.org (XBRL International). Entity identity is resolved by LEI via the public-domain GLEIF register. This is reference data, not investment advice.